Venus Remedies Limited (NSE:VENUSREM) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Venus Remedies Limited (NSE:VENUSREM) shares have continued their recent momentum with a 26% gain in the last month alone. Looking back a bit further, it’s encouraging to see the stock is up 44% in the last year.
In spite of the firm bounce in price, given about half the companies in India have price-to-earnings ratios (or “P/E’s”) above 30x, you may still consider Venus Remedies as an attractive investment with its 16.3x P/E ratio. However, the P/E might be low for a reason and it requires further investigation to determine if it’s justified.
Venus Remedies certainly has been doing a great job lately as it’s…
